Pharma Sessions

In this special episode of Pharma Sessions, host Jonathan Kaskey steps behind the mic solo to share the evolving vision for the podcast and the personal career shift that inspired it. What began as a show centered on medical affairs is now broadening to reflect the realities of modern pharma: commercial strategy, analytics, AI, organizational change, and the people navigating it all. Jonathan shares the story behind his move to XSUNT and why building something meaningful again became the driving force behind his next chapter. Along the way, he reflects on what AI should be doing in pharma, why niche, domain-specific tools outperform generic platforms, and how teams can move beyond manual reporting toward real strategic impact.

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Martin McLaughlin, former Head of Launch and Business Excellence at Takeda, to share the frameworks and lessons that help pharma organizations align people, processes, performance, and technology for success.

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jens Øllgaard, Head of Customer Experience at Novo Nordisk, to discuss how forward-thinking pharma leaders are dismantling silos between medical and commercial teams, leveraging AI-driven insights, and fundamentally reimagining how field teams create value in an era of declining physician access.

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Anindita (Ani) Sinha, Vice President of Commercial Operations at Shionogi, to unpack practical approaches to drive market success, from translating complex data into actionable field strategies to building effective cross-functional partnerships between commercial and medical teams.

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Caitlyn Krebs, Co-Founder and CEO of Nalu Bio, to share insights about AI-driven drug development, specifically targeting the endocannabinoid system (ECS) for therapeutic development in pain management, inflammation, and women’s health.